Prelude Therapeutics
Clinical trials sponsored by Prelude Therapeutics, explained in plain language.
-
Experimental cancer drug trial halted early – what we know
Disease control TerminatedThis early-stage study tested an experimental pill called PRT7732 in people with advanced solid tumors that have a specific genetic change (SMARCA4 mutation). The main goals were to check safety, find the right dose, and see if the drug shrinks tumors. The study was terminated ea…
Phase: PHASE1 • Sponsor: Prelude Therapeutics • Aim: Disease control
Last updated Jun 15, 2026 19:07 UTC
-
Experimental combo for rare Gene-Mutated cancers halted early
Disease control TerminatedThis study tested a new drug (PRT3789) combined with the immunotherapy pembrolizumab in people with advanced or spreading solid tumors that have a specific genetic change called SMARCA4 mutation. The goal was to see if the combination was safe and could shrink tumors. Only 6 part…
Phase: PHASE2 • Sponsor: Prelude Therapeutics • Aim: Disease control
Last updated Jun 15, 2026 19:02 UTC